[
  {
    "ts": null,
    "headline": "3 MedTech Stocks Benefiting From Favorable Product Mix Shifts",
    "summary": "ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.",
    "url": "https://finnhub.io/api/news?id=44f04aa907d26732f3c33eafd994906fa3818290ec07c5e88868b8e48ce2431b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768329600,
      "headline": "3 MedTech Stocks Benefiting From Favorable Product Mix Shifts",
      "id": 138092371,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable growth across MedTech.",
      "url": "https://finnhub.io/api/news?id=44f04aa907d26732f3c33eafd994906fa3818290ec07c5e88868b8e48ce2431b"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: Boston Scientific strengthens urology portfolio with Valencia Technologies acquisition",
    "summary": "Valencia’s eCoin implantable tibial nerve stimulation (ITNS) system for urge urinary incontinence (UUI) treatment gained FDA approval in 2022.",
    "url": "https://finnhub.io/api/news?id=524b66ea9f915d5cd4cd9a3d8a31c91e899039a9871f83bbd153bd74e0bdab3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768327276,
      "headline": "JPM26: Boston Scientific strengthens urology portfolio with Valencia Technologies acquisition",
      "id": 138086814,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Valencia’s eCoin implantable tibial nerve stimulation (ITNS) system for urge urinary incontinence (UUI) treatment gained FDA approval in 2022.",
      "url": "https://finnhub.io/api/news?id=524b66ea9f915d5cd4cd9a3d8a31c91e899039a9871f83bbd153bd74e0bdab3d"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: Medtronic touts ‘multi-billion’ dollar potential of key markets",
    "summary": "Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the near future.",
    "url": "https://finnhub.io/api/news?id=bdb633431e5d592028534d57c9f2aac262bb855deb614fb416ce3350a2ca887b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768324780,
      "headline": "JPM26: Medtronic touts ‘multi-billion’ dollar potential of key markets",
      "id": 138086815,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the near future.",
      "url": "https://finnhub.io/api/news?id=bdb633431e5d592028534d57c9f2aac262bb855deb614fb416ce3350a2ca887b"
    }
  },
  {
    "ts": null,
    "headline": "Brookdale Senior 4Q25 Sneak Peek: Occupancy Volume Rises to 82.5%",
    "summary": "BKD's 4Q25 weighted average occupancy rises to 82.5%, capping a year of gains as resident fees climb.",
    "url": "https://finnhub.io/api/news?id=ce1bf0df73cac7f9b82bf5ddeff25a7bdaa26db2318a54d4c0df4cad89aaefc0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768321140,
      "headline": "Brookdale Senior 4Q25 Sneak Peek: Occupancy Volume Rises to 82.5%",
      "id": 138086816,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BKD's 4Q25 weighted average occupancy rises to 82.5%, capping a year of gains as resident fees climb.",
      "url": "https://finnhub.io/api/news?id=ce1bf0df73cac7f9b82bf5ddeff25a7bdaa26db2318a54d4c0df4cad89aaefc0"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript",
    "summary": "Boston Scientific Corporation (BSX) 44th Annual J.P.",
    "url": "https://finnhub.io/api/news?id=e8138c9b5a9a6572b2254e940dbd167786c30d532ac26874ca19ac3cf1f233a3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768319759,
      "headline": "Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript",
      "id": 138088381,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific Corporation (BSX) 44th Annual J.P.",
      "url": "https://finnhub.io/api/news?id=e8138c9b5a9a6572b2254e940dbd167786c30d532ac26874ca19ac3cf1f233a3"
    }
  },
  {
    "ts": null,
    "headline": "What's Powering J&J's MedTech Growth Ahead of Q4 Release?",
    "summary": "JNJ's MedTech unit is gaining momentum from cardiovascular strength and new products, even as China pressure lingers into the next quarter.",
    "url": "https://finnhub.io/api/news?id=f85c3faba5d5edacb66dd7bb56ac9b9e68dfef94d6bd3d8a2ebdf1b63e56dd0c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768308480,
      "headline": "What's Powering J&J's MedTech Growth Ahead of Q4 Release?",
      "id": 138084497,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "JNJ's MedTech unit is gaining momentum from cardiovascular strength and new products, even as China pressure lingers into the next quarter.",
      "url": "https://finnhub.io/api/news?id=f85c3faba5d5edacb66dd7bb56ac9b9e68dfef94d6bd3d8a2ebdf1b63e56dd0c"
    }
  },
  {
    "ts": null,
    "headline": "1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off",
    "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
    "url": "https://finnhub.io/api/news?id=93d53e12008ead3f8c0e1de60354682cd7089c40662b7b9b0483bfb540fba915",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768278809,
      "headline": "1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off",
      "id": 138084566,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
      "url": "https://finnhub.io/api/news?id=93d53e12008ead3f8c0e1de60354682cd7089c40662b7b9b0483bfb540fba915"
    }
  }
]